In accordance with Evi1-reporter CML-CP model, our single-cell analysis of clinical CML-CP cases revealed the highest EVI1 in stem cell-enriched CD34+CD38–CD90+ cells, reflecting CML-CP as a stem cell disease (Figure 1a). This evidence concerns the gene CD38 and chronic myelogenous leukemia, BCR-ABL1 positive.